Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Sanitation tents abridged 5May2020 V2 CTL
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Breastfeeding_Abridged_09Apr2020_SVA
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
PrognosticFactors Abridged 23APR2020 Version3 EOS PPR
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Covid-PSMID
> NOTE: The COVID-19 Living Clinical Practice Guidelines contains UPDATED recommendations and evidence summaries. Click here to be redirected to the COVID LCPG.
Through the volunteer work of more than 50 EBM practitioners, methodologists and students from the UP Institute of Clinical Epidemiology and Asia-Pacific Center for Evidence-Based HealthCare, Read more “Rapid Evidence Reviews on COVID-19 Management”
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Vertical-transmission-Abridged-06Apr2020-JT
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Lopinavir_interferon_abridged_5Apr2020_MAI
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
lopinavir_ritonavir_abridged_17Apr2020_V3_MV_IGC
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Remdesivir_Abridged_27May2020 IGC_TL
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.